01 9Levemir
Main Therapeutic Indication : Diabetes
Currency : USD
2020 Revenue in Millions : 1,143
2019 Revenue in Millions : 1,514
Growth (%) : -24
Main Therapeutic Indication : Diabetes
Currency : USD
2021 Revenue in Millions : 865
2020 Revenue in Millions : 1,124
Growth (%) : -19
Main Therapeutic Indication : Diabetes
Currency : USD
2022 Revenue in Millions : 668
2021 Revenue in Millions : 865
Growth (%) : -23
Main Therapeutic Indication : Diabetes
Currency : USD
2023 Revenue in Millions : 572
2022 Revenue in Millions : 668
Growth (%) : -14
Main Therapeutic Indication : Diabetes
Currency : USD
2024 Revenue in Millions : 647
2023 Revenue in Millions : 572
Growth (%) : 13
Main Therapeutic Indication : Diabetes
Currency : USD
2016 Revenue in Millions : 2,392
2015 Revenue in Millions : 2,562
Growth (%) : -7
Main Therapeutic Indication : Diabetes
Currency : USD
2017 Revenue in Millions : 2,400
2016 Revenue in Millions : 2,904
Growth (%) : -17
Main Therapeutic Indication : Diabetes
Currency : USD
2018 Revenue in Millions : 1,679
2017 Revenue in Millions : 2,118
Growth (%) : -21%
Main Therapeutic Indication : Diabetes
Currency : USD
2019 Revenue in Millions : 1,396
2018 Revenue in Millions : 1,679
Growth (%) : -17
